Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Short Interest Up 481.9% in January

by · The Markets Daily

Invesco Pharmaceuticals ETF (NYSEARCA:PJP – Get Free Report) saw a significant increase in short interest in January. As of January 15th, there was short interest totaling 40,386 shares, an increase of 481.9% from the December 31st total of 6,940 shares. Based on an average daily trading volume, of 141,970 shares, the short-interest ratio is currently 0.3 days. Currently, 1.1% of the shares of the stock are short sold. Currently, 1.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 141,970 shares, the short-interest ratio is currently 0.3 days.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of PJP. Envestnet Asset Management Inc. lifted its holdings in shares of Invesco Pharmaceuticals ETF by 5.6% during the 2nd quarter. Envestnet Asset Management Inc. now owns 19,547 shares of the company’s stock worth $1,561,000 after acquiring an additional 1,040 shares during the period. Joseph Group Capital Management increased its stake in Invesco Pharmaceuticals ETF by 9.9% in the second quarter. Joseph Group Capital Management now owns 21,242 shares of the company’s stock valued at $1,697,000 after acquiring an additional 1,907 shares during the last quarter. Trilogy Capital Inc. acquired a new position in Invesco Pharmaceuticals ETF during the second quarter valued at approximately $1,330,000. DHJJ Financial Advisors Ltd. bought a new stake in Invesco Pharmaceuticals ETF during the second quarter worth $28,000. Finally, AE Wealth Management LLC lifted its stake in Invesco Pharmaceuticals ETF by 21.5% during the second quarter. AE Wealth Management LLC now owns 717 shares of the company’s stock worth $57,000 after purchasing an additional 127 shares during the last quarter.

Invesco Pharmaceuticals ETF Price Performance

NYSEARCA:PJP traded up $0.60 during trading hours on Thursday, reaching $105.22. 14,614 shares of the company were exchanged, compared to its average volume of 88,174. The company has a market capitalization of $395.63 million, a P/E ratio of 15.59 and a beta of 0.50. Invesco Pharmaceuticals ETF has a 1-year low of $72.25 and a 1-year high of $108.40. The business has a 50 day moving average of $105.57 and a 200 day moving average of $96.51.

Invesco Pharmaceuticals ETF Company Profile

(Get Free Report)

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.

Recommended Stories